Compare Newegg Commerce Inc (NEGG) vs Oscar Health Inc (OSCR) Price & Performance

NEGG trades at $15.17, down 0.98% on the day, with a bearish technical signal from moving averages but recent earnings beats showing improvement. The company reported Q2 2026 EPS of $0.11, beating expectations by $0.51, while revenue trends show stabilization after declines from 2022-2024. Valuation metrics include a P/E of 33.27 and P/S of 0.23, with improving profitability margins.

The outlook suggests cautious optimism as NEGG demonstrates operational improvement with four consecutive earnings beats and positive net income projected for 2026. Key risks include negative operating cash flow and competitive e-commerce pressures, while the single analyst coverage maintains a Buy rating with 100% consensus.

Oscar Health (OSCR) trades at $33.01, up 2.36% today and approaching its 52-week high of $33.10. The stock shows strong technical momentum with bullish moving averages and has surged 109% year-to-date. Fundamentally, revenue grew from $11.7B in 2025 to $15.3B in 2026, with net income turning positive at $551M. Recent earnings beats and membership growth to 2.96 million support the bullish case, though valuation metrics like P/E of 25.39 and P/B of 4.97 suggest premium pricing.

Outlook remains positive with strong revenue growth and profitability improvements, but risks include high valuation multiples and dependence on sustained membership growth. Analyst consensus is mixed with 27% buy ratings and a $30.67 price target below current levels, indicating caution despite technical strength. Key catalysts include continued operational efficiency gains and AI integration, while medical cost management remains critical.